Trump NIH Cuts Ruled Illegal | US News
- BOSTON—A federal judge in Massachusetts has ruled that the Trump administration's cuts to national Institutes of Health (NIH) grants were unlawful.
- Young stated the NIH violated federal law by arbitrarily canceling over $1 billion in research grants linked to diversity, equity, and inclusion (DEI) initiatives.
- The lawsuit, filed in April by a group of researchers, claimed that hundreds of critical research projects were halted due to an "ideological purge." The plaintiffs argued that...
A federal judge has declared the Trump management’s NIH grant cuts illegal, a ruling with notable implications. Judge William Young found that the terminations, impacting over $1 billion in research funds, violated federal law by targeting diversity, equity, and inclusion (DEI) initiatives.The judge, appointed by Reagan, called the cuts discriminatory based on race and against the LGBTQ community. This powerful decision challenges the NIH’s discretion and underscores the role of DEI in funding. The director of NIH has admitted that the past administration “went too far.” News Directory 3 brings you this critical update. Discover what’s next as the legal battle continues and the grants are restored.
Federal Judge Rebukes NIH Grant Terminations as Discriminatory
Updated June 16, 2025
BOSTON—A federal judge in Massachusetts has ruled that the Trump administration’s cuts to national Institutes of Health (NIH) grants were unlawful. Judge William Young vacated the terminations, ordering the restoration of many grants.
Young stated the NIH violated federal law by arbitrarily canceling over $1 billion in research grants linked to diversity, equity, and inclusion (DEI) initiatives. The judge, appointed by president Ronald Reagan, said the cuts represented ”racial discrimination and discrimination against America’s LGBTQ community.”
The lawsuit, filed in April by a group of researchers, claimed that hundreds of critical research projects were halted due to an “ideological purge.” The plaintiffs argued that the reasons for termination—connections with DEI and gender identity—were vague and lacked concrete explanation. Terminated grants included programs focusing on women, racial minorities, LGBTQ health, cancer, youth suicide, and bone health. The government maintained the court lacked jurisdiction and the NIH has discretion in setting priorities.
Young reinstated grants awarded to organizations and Democratic-led states that sued over the terminations, hinting at a perhaps broader decision as the case proceeds. He added that in his 40 years on the bench, he had “never seen evidence of racial discrimination like this.” The role of DEI in research funding remains a key point of contention.
”I didn’t take this job to terminate grants,” said Jay Bhattacharya, director of the NIH.
The ruling follows admissions from NIH Director Jay Bhattacharya that the trump administration went too far in slashing biomedical research grants. Bhattacharya, who left Stanford University to join the administration, made these remarks during a Senate committee hearing examining the cuts and proposed budget reductions. He stated that efforts were underway to restore some funding and that an appeals process had been created, with “many” cuts already reversed. Bhattacharya emphasized his goal was to advance the health needs of the American people through research, not to terminate grants.
What’s next
The NIH is expected to reinstate the affected grants while the legal battle continues, potentially leading to a more comprehensive ruling on the scope and limitations of the agency’s discretion in setting funding priorities and the role of diversity, equity and inclusion in biomedical research.